Terms: = Skin cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Clinical Outcome
14 results:
1. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract] [Full Text] [Related]
2. Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series.
Straub Hogan MM; Spieker AJ; Orejudos M; Gheit T; Herfs M; Tommasino M; Sanchez DF; Fernandez-Nestosa MJ; Pena MDCR; Gordetsky JB; Epstein JI; Canete-Portillo S; Gellert LL; Prieto Granada CN; Magi-Galluzzi C; Cubilla AL; Giannico GA
Mod Pathol; 2022 Aug; 35(8):1101-1109. PubMed ID: 35190664
[TBL] [Abstract] [Full Text] [Related]
3. TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.
Kim SK; Kim JH; Han JH; Cho NH; Kim SJ; Kim SI; Choo SH; Kim JS; Park B; Kwon JE
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1125-1135. PubMed ID: 33635430
[TBL] [Abstract] [Full Text] [Related]
4. Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.
Brøndum L; Alsner J; Sørensen BS; Maare C; Johansen J; Primdahl H; Evensen JF; Kristensen CA; Andersen LJ; Overgaard J; Eriksen JG
Acta Oncol; 2018 Sep; 57(9):1159-1164. PubMed ID: 29771169
[TBL] [Abstract] [Full Text] [Related]
5. Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
Foster CC; Lee AY; Furtado LV; Hart J; Alpert L; Xiao SY; Hyman NH; Sharma MR; Liauw SL
PLoS One; 2018; 13(3):e0194234. PubMed ID: 29522569
[TBL] [Abstract] [Full Text] [Related]
6. Activated MEK cooperates with cdkn2a and Pten loss to promote the development and maintenance of melanoma.
Yang H; Kircher DA; Kim KH; Grossmann AH; VanBrocklin MW; Holmen SL; Robinson JP
Oncogene; 2017 Jul; 36(27):3842-3851. PubMed ID: 28263969
[TBL] [Abstract] [Full Text] [Related]
7. A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck.
Villada G; Kryvenko ON; Campuzano-Zuluaga G; Kovacs C; Chapman J; Gomez-Fernandez C
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):126-131. PubMed ID: 27438511
[TBL] [Abstract] [Full Text] [Related]
8. Correlation Between the Severity of Cetuximab-Induced skin Rash and clinical outcome for Head and Neck cancer Patients: The RTOG Experience.
Bar-Ad V; Zhang QE; Harari PM; Axelrod R; Rosenthal DI; Trotti A; Jones CU; Garden AS; Song G; Foote RL; Raben D; Shenouda G; Spencer SA; Harris J; Le QT
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1346-1354. PubMed ID: 27212198
[TBL] [Abstract] [Full Text] [Related]
9. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
J Clin Pathol; 2014 Jun; 67(6):520-8. PubMed ID: 24607493
[TBL] [Abstract] [Full Text] [Related]
10. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.
Schrama D; Peitsch WK; Zapatka M; Kneitz H; Houben R; Eib S; Haferkamp S; Moore PS; Shuda M; Thompson JF; Trefzer U; Pföhler C; Scolyer RA; Becker JC
J Invest Dermatol; 2011 Aug; 131(8):1631-8. PubMed ID: 21562568
[TBL] [Abstract] [Full Text] [Related]
11. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.
Jönsson G; Busch C; Knappskog S; Geisler J; Miletic H; Ringnér M; Lillehaug JR; Borg A; Lønning PE
Clin Cancer Res; 2010 Jul; 16(13):3356-67. PubMed ID: 20460471
[TBL] [Abstract] [Full Text] [Related]
12. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
[TBL] [Abstract] [Full Text] [Related]
13. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
[TBL] [Abstract] [Full Text] [Related]
14. p16(ink4a) gene alterations are frequent in lesions of mycosis fungoides.
Navas IC; Ortiz-Romero PL; Villuendas R; Martínez P; García C; Gómez E; Rodriguez JL; García D; Vanaclocha F; Iglesias L; Piris MA; Algara P
Am J Pathol; 2000 May; 156(5):1565-72. PubMed ID: 10793068
[TBL] [Abstract] [Full Text] [Related]
